๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease

โœ Scribed by D. Prisco; R. Paniccia; B. Bandinelli; A. M. Gori; M. Attanasio; B. Giusti; M. Comeglio; R. Abbate; G. F. Gensini; G. G. Neri Serneri

Publisher
Springer
Year
1998
Tongue
English
Weight
423 KB
Volume
28
Category
Article
ISSN
0940-5437

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A multicenter comparison of nicorandil a
A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease
โœ Jun Sasaki; Yoshihisa Saeki; Kazuya Kawasaki; Morio Umeno; Kenjiro Ikeda; Koichi ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 328 KB

The effects of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in 37 patients with ischemic heart disease were examined in a randomized, multicenter study. Nicorandil (n = 20, 10-40 mg/day, b.i.d.) and diltiazem (n = 17, 60-240 mg/day, b.i.d.) were administered for 12

The effects of nisoldipine on left ventr
The effects of nisoldipine on left ventricular filling rate in patients with ischemic heart disease measured with radionuclide gated blood pool scintigraphy
โœ Anton C. Otto; Andries Aswegen; Charles P. Herbst; M. Ann Sweetlove; Annalie C. ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 339 KB

Nisoldipine is a newly developed calcium channel blocker with outstanding vasodilatory properties especially with regard to the coronary arteries. Thus it may find wide-spread application as a therapeutic agent in various ischemic heart disease syndromes. The purpose of this study was to evaluate th